We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-1.56%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$672M
AUM Growth
+$54.8M
Cap. Flow
+$50.6M
Cap. Flow %
7.53%
Top 10 Hldgs %
35.69%
Holding
5,893
New
1,202
Increased
1,600
Reduced
1,403
Closed
1,568

Sector Composition

Rank Sector Weight
1 Technology 5.35%
2 Consumer Discretionary 3.08%
3 Materials 2.71%
4 Industrials 2.51%
5 Financials 2.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRO
3801
DELISTED
Marathon Oil Corporation
MRO
$1K ﹤0.01%
118
-11,475
-99% -$107K
NTBL
3802
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$1K ﹤0.01%
+7
New +$843
EGRX
3803
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$1K ﹤0.01%
30
-70
-70% -$4.44K
CTR
3804
DELISTED
ClearBridge MLP and Midstream Total Return Fund Inc.
CTR
$1K ﹤0.01%
14
-561
-98% -$26.6K
MCBC
3805
DELISTED
Macatawa Bank Corp
MCBC
$1K ﹤0.01%
153
+139
+993% +$834
CAMP
3806
DELISTED
CalAmp Corp.
CAMP
$1K ﹤0.01%
4
-56
-93% -$22.9K
CTHR
3807
DELISTED
Charles & Colvard Ltd
CTHR
$1K ﹤0.01%
121
+38
+46% +$388
OPGN
3808
DELISTED
OpGen, Inc
OPGN
0
SMMF
3809
DELISTED
Summit Financial Group, Inc.
SMMF
$1K ﹤0.01%
+53
New +$688
GGE
3810
DELISTED
Green Giant Inc. Common Stock
GGE
$1K ﹤0.01%
280
+30
+12% +$92
HTY
3811
DELISTED
JOHN HANCOCK TAX-ADVANTAGED GLOBAL SHAREHOLDER YIELD FUND
HTY
$1K ﹤0.01%
105
+5
+5% +$52
EIGR
3812
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$1K ﹤0.01%
3
-28
-90% -$13.9K
MFV
3813
DELISTED
MFS SPECIAL VALUE TRUST
MFV
$1K ﹤0.01%
112
-443
-80% -$2.24K
SCTL
3814
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$1K ﹤0.01%
+227
New +$1.4K
NEPT
3815
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
0
MDVL
3816
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
$1K ﹤0.01%
+1
New +$984
ARAV
3817
DELISTED
Aravive, Inc. Common Stock
ARAV
$1K ﹤0.01%
22
-111
-83% -$5.89K
GPP
3818
DELISTED
Green Plains Partners LP
GPP
$1K ﹤0.01%
+74
New +$1.02K
FRTX
3819
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$1K ﹤0.01%
1
-1
-50% -$1.15K
SGEN
3820
DELISTED
Seagen Inc. Common Stock
SGEN
$1K ﹤0.01%
+30
New +$1.01K
AENZ
3821
DELISTED
Aenza S.A.A.
AENZ
$1K ﹤0.01%
+73
New +$726
SOFO
3822
DELISTED
Sonic Foundry, Inc. Common Stock
SOFO
$1K ﹤0.01%
135
-398
-75% -$2.22K
CYTO
3823
DELISTED
Altamira Therapeutics Ltd
CYTO
0
HCCI
3824
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
$1K ﹤0.01%
100
-497
-83% -$4.36K
LOV
3825
DELISTED
Spark Networks SE American Depositary Shares
LOV
$1K ﹤0.01%
+642
New +$2.05K

Similar funds

Tower Research Capital (TRC)'s Q1 2016 Portfolio in Review

As of Q1 2016, Tower Research Capital (TRC) held 5,893 positions worth $672M, up 8.9% from $617M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Tower Research Capital (TRC) deployed $50.6M of net new capital in Q1 2016, opening 1,202 new positions and adding to 1,600 existing holdings. Its largest new stake was State Street Industrial Select Sector SPDR ETF: 287,194 shares worth $15.9M.

By sector, the portfolio is most concentrated in Technology at 5.3% of assets, up from 1.4% a quarter earlier, followed by Consumer Discretionary and Materials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $227M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2016 buy was State Street Industrial Select Sector SPDR ETF: 287,194 shares worth $15.9M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q1 2016, an estimated $52.3M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $227M.
  • Tower Research Capital (TRC) fully exited iShares Core S&P 500 ETF in Q1 2016, selling an estimated $9.03M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 36% of its $672M portfolio in Q1 2016.
  • Tower Research Capital (TRC) opened 1,202 new positions and closed 1,568 in Q1 2016.
  • Tower Research Capital (TRC)'s portfolio value rose 8.9% quarter-over-quarter to $672M.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2016, filed 16 May 2016.